-
The emerging field of nanotechnology — the science of "building small" — holds enormous promise in almost every field, including medicine, cosmetics, information technology, optics, electronics, and materials development.
-
Employee safety is patient safety. After all, those employees are your patients, and by improving their work environment and teaching them about safety measures, you help them protect their patients.
-
Every year, thousands of new immigrants to the United States start jobs that promise hope for a new life but may bear safety and health risks if no one at their new jobs can communicate in their native language.
-
Washington state's new law mandating hospitals provide mechanical lift equipment to safely move and position patients is just the latest sign that nurses are taking charge of their ergonomic health.
-
Infection control professionals adopting policies requiring workers to sign declination statements if they forgo influenza vaccination can expect to run into a persistent group of "refuseniks" with varied reasons for their recalcitrance.
-
Obesity is a major contributor to employee health costs, responsible for 2% to 3% of all medical claims dollars, a new health research report finds.
-
The 55th Annual Scientific Sessions of the American College of Cardiology (ACC; Bethesda, Maryland), held here in mid-March, showcased new developments in a wide range of diagnostic and therapeutic technologies applicable to cardiovascular disease, including interventional device technologies, invasive imaging and diagnosis, technologies for diagnosis and treatment of heart rhythm disorders, and new technologies for stroke treatment.
-
Just before presstime for this issue of Cardiovascular Device Update, Boston Scientific (Natick, Massachusetts) and Guidant (Indianapolis) reported that the FTC granted antitrust approval for their $27.2 billion merger and they expected to finalize the deal April 21.
-
C. R. Bard (Murray Hill, New Jersey) completed its previously reported acquisition of Venetec International (San Diego, California).
-
While most of the biggest headlines in cardiovascular news last year, and so far this year, have been focused on the rhythm management space of cardiovascular devices - pacemakers and implantable cardioverter defibrillators (ICDs) and the problems with those devices - the cardio sector making the most clinical noise probably has been that of ventricular assist devices (VADs).
